Cadrenal Therapeutics Inc...

17.43
-1.57 (-8.26%)
At close: Mar 03, 2025, 3:59 PM
17.40
-0.17%
After-hours: Mar 03, 2025, 04:00 PM EST

Cadrenal Therapeutics Common Stock Income Statement

Year FY23 FY22
Revenue n/a n/a
Cost of Revenue 1.98K 1.27K
Gross Profit -1.98K -1.27K
Operating Income -7.63M -2.7M
Interest Income 249.09K n/a
Pretax Income -8.36M -6.71M
Net Income -8.36M -6.71M
Selling & General & Admin 3.55M 2.31M
Research & Development 4.08M 392.86K
Other Expenses n/a n/a
Operating Expenses 7.63M 2.7M
Interest Expense 17.1K 107.11K
Selling & Marketing Expenses n/a n/a
Cost & Expenses 7.63M 2.7M
Income Tax n/a 4.00
Shares Outstanding (Basic) 868.18K 775.64K
Shares Outstanding (Diluted) 868.18K 775.64K
EPS (Basic) -9.63 -8.66
EPS (Diluted) -9.63 -8.66
EBITDA -8.34M -6.61M
Depreciation & Amortization 1.98K 1.27K